Home › Myelofibrosis › Connecticut › New Haven
Myelofibrosis clinical trials in New Haven, CT
4 studies for Myelofibrosis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- Yale School of Medicine, New Haven
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RecruitingPhase 3
- Yale University School Of Medicine, New Haven
Pacritinib Effectiveness in Real-world Settings
RecruitingObservational study
- Yale School of Medicine, New Haven
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Yale Cancer Center, New Haven
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Durham, NC12 studies
- Boston, MA12 studies
- Columbus, OH11 studies
- Seattle, WA11 studies
- Salt Lake City, UT10 studies
- Miami, FL10 studies
- Cleveland, OH9 studies
- Tampa, FL9 studies
- Atlanta, GA9 studies
- Nashville, TN9 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.